Suzanne Sawochka Hooper's Net Worth
$18.6 Million
Who is Suzanne Sawochka Hooper?
Suzanne Sawochka Hooper has an estimated net worth of $18.6 Million. This is based on reported shares across multiple companies, which include NGM BIOPHARMACEUTICALS INC, Jazz Pharmaceuticals plc, and Eidos Therapeutics, Inc..
SEC CIK
Suzanne Sawochka Hooper's CIK is 0001544589
Past Insider Trading and Trends
2014 was Suzanne Sawochka Hooper's most active year for acquiring shares with 11 total transactions. Suzanne Sawochka Hooper's most active month to acquire stocks was the month of January. 2014 was Suzanne Sawochka Hooper's most active year for disposing of shares, totalling 21 transactions. Suzanne Sawochka Hooper's most active month to dispose stocks was the month of January. 2018 saw Suzanne Sawochka Hooper paying a total of $654,221.88 for 46,426 shares, this is the most they've acquired in one year. In 2018 Suzanne Sawochka Hooper cashed out on 27,908 shares for a total of $2,219,914.35, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NGM BIOPHARMACEUTICALS INC (NGM) Snapshot price: $1.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.00K |
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
∞
| 7K |
$16.00 | $112,000.00 | 7K |
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $123.23
EVP & General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.51% | -1.45K |
$92.25 | -$804,629.85 | 39.74K |
Scheduled
|
Feb 25 - Feb 27
| ||
Form 4
| -0.09% | -39.00 |
$93.52 | -$313,155.29 | 41.18K |
Scheduled
|
Dec 14
| ||
Form 4
| +7.14% | 2.73K |
$106.93 | -$737,582.97 | 40.98K |
May 11 - May 14
| |||
Form 4
| -3.14% | -1.24K |
$143.39 | -$177,660.21 | 38.25K |
Mar 5
| |||
Form 4
| +31.24% | 9.4K |
—
|
—
| 39.49K |
Mar 1
| |||
Form 4
| -7.13% | -2.31K |
$146.08 | -$337,294.00 | 30.09K |
Feb 26 - Feb 27
| |||
Form 4
| -12.41% | -4.58K |
$160.00 | -$732,800.00 | 32.32K |
Scheduled
|
Jul 20
| ||
Form 4
| -1.13% | -420.00 |
$160.00 | -$67,200.00 | 36.9K |
Scheduled
|
Jun 23
| ||
Form 4
| -6.31% | -2.50K |
$160.00 | -$400,000.00 | 37.15K |
Scheduled
|
May 9
| ||
Form 4
| -5.93% | -2.50K |
$160.00 | -$400,000.00 | 39.65K |
Scheduled
|
Apr 27
| ||
Form 4
| -4.72% | -2.09K |
$132.81 | -$277,174.47 | 42.15K |
Mar 6
| |||
Form 4
| +29.21% | 10K |
—
|
—
| 44.24K |
Mar 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -3.50% | -2.51K |
$136.97 | -$343,931.67 | 69.24K |
Feb 27
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -11.06% | -4.57K |
$150.01 | -$684,795.65 | 36.7K |
Aug 9
| |||
Form 4
| -4.26% | -1.83K |
$127.84 | -$234,202.88 | 41.14K |
Mar 7
| |||
Form 4
| -2.14% | -939.00 |
$121.58 | -$114,163.62 | 42.97K |
Feb 29
| |||
Form 4
| +23.19% | 8.27K |
$125.00 | -$91,875.00 | 43.91K |
Feb 25 - Feb 26
| |||
Form 4
| -5.28% | -2.00K |
$125.00 | -$250,006.00 | 35.85K |
Scheduled
|
Oct 21
| ||
Form 4
| -9.56% | -4.00K |
$177.82 | -$711,280.00 | 37.85K |
Scheduled
|
Aug 11
| ||
Form 4
| -9.83% | -4.57K |
$181.48 | -$828,456.20 | 41.85K |
Aug 10
| |||
Form 4
|
—
|
0
|
$112.31 | -$523,840.00 | 46.42K |
Scheduled
|
Jul 14
| ||
Form 4
|
—
|
0
|
$110.00 | -$505,320.00 | 46.42K |
Scheduled
|
Jun 9
| ||
Form 4
| -4.00% | -1.93K |
$110.34 | -$598,321.41 | 46.3K |
Scheduled
|
May 12
| ||
Form 4
| -7.66% | -4.00K |
$181.45 | -$725,800.00 | 48.22K |
Scheduled
|
Apr 14
| ||
Form 4
|
—
|
0
|
$108.60 | -$228,654.03 | 52.22K |
Scheduled
|
Mar 10
| ||
Form 4
| -3.84% | -2.09K |
$174.76 | -$364,724.12 | 52.22K |
Mar 5
| |||
Form 4
| +14.16% | 6.74K |
$170.09 | -$159,714.51 | 54.31K |
Feb 26 - Feb 27
| |||
Form 4
|
—
|
0
|
$106.87 | -$222,249.57 | 47.58K |
Scheduled
|
Feb 10
| ||
Form 4
| -0.46% | -220.00 |
$104.28 | -$212,679.90 | 47.58K |
Scheduled
|
Dec 5 - Jan 13
| ||
Form 4
| -1.05% | -505.00 |
$112.81 | -$268,039.07 | 47.8K |
Scheduled
|
Dec 9
| ||
Form 4
| -2.40% | -1.19K |
$110.23 | -$290,327.15 | 48.25K |
Scheduled
|
Nov 11
| ||
Form 4
| -2.34% | -1.19K |
$96.10 | -$237,996.84 | 49.43K |
Scheduled
|
Oct 14 - Oct 16
| ||
Form 4
| -2.29% | -1.19K |
$107.42 | -$279,900.39 | 50.62K |
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$98.42 | -$68,814.39 | 51.8K |
Scheduled
|
Aug 15
| ||
Form 4
| -9.99% | -5.75K |
$133.71 | -$768,853.65 | 51.8K |
Scheduled
|
Aug 11 - Aug 12
| ||
Form 4
|
—
|
0
|
$100.92 | -$200,439.01 | 57.55K |
Scheduled
|
Jul 8
| ||
Form 4
|
—
|
0
|
$93.42 | -$62,144.39 | 57.13K |
Scheduled
|
May 27
| ||
Form 4
|
—
|
0
|
$93.42 | -$62,144.39 | 57.13K |
Scheduled
|
Apr 17
| ||
Form 4
| -2.64% | -1.55K |
$157.60 | -$243,807.20 | 57.13K |
Mar 5
| |||
Form 4
| +20.54% | 10K |
—
|
—
| 58.68K |
Feb 27
| |||
Form 4
| -6.76% | -3.50K |
$80.88 | -$283,484.40 | 48.33K |
Aug 9
| |||
Form 4
| +45.17% | 16K |
—
|
—
| 51.42K |
Mar 5
| |||
Form 4
|
∞
| 35K |
—
|
—
| 35K |
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eidos Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||